Publication | Open Access
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
155
Citations
34
References
2011
Year
The results of this study suggest that genetic silencing or inhibition of TAK1 kinase activity in vivo is a potential therapeutic approach to reversal of the intrinsic chemoresistance of pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1